Niklas strandell

Pharmacovigilance seeks to detect and describe adverse drug reactions early. Ideally, we would like to see objective evidence that a chosen signal detection approach can be expected to be effective. The development and evaluation of evidence-based methods require benchmarks for signal detection performance, and recent years have seen unprecedented efforts to build such reference sets. Here, we. 1 2 Reported suspicion of interactions as noted by the reporter in a case narrative, the assignment of the two drugs as interacting or through an ADR term; co-reporting of effect increased with the drug pair and by the ?(025) each provide unique information to highlight adverse drug interactions before . 3 4 2011 (English) In: Drug Safety, ISSN 0114-5916, E-ISSN 1179-1942, Vol. 34, no 3, p. 253-66 Article in journal (Refereed) Published Abstract [en] Background: Adverse drug interaction surveillance in collections of Individual Case Safety Reports (ICSRs) remains underdeveloped. 5 Niklas Strandell is on Facebook. Join Facebook to connect with Niklas Strandell and others you may know. Facebook gives people the power to share and makes the world more open and connected. 6 Johanna Strandell,1,2 Ola Caster,1,3 Andrew Bate,1,4 Niklas Nore?n1,5 and I. Ralph Edwards1 1 Uppsala Monitoring Centre, Uppsala, Sweden 2 Department of Drug Research/Clinical Pharmacology, Linko?ping University, Linko?ping, Sweden 3 Department of Computer and Systems Sciences, Stockholm University, Stockholm, Sweden. 7 8 Niklas Strandell finns pa Facebook Ga med i Facebook for att komma i kontakt med Niklas Strandell och andra som du kanner. 9 Kontakta Niklas Strandell, 42 ar, Anderslov. 10 11